Abstract. The RCC1 gene, a regulator for the onset of chromosome condensation was found to encode a protein with a molecular mass of 45 kD, determined using the antibody against the synthetic peptides prepared according to the amino acid sequence of the putative RCC1 protein. The p45 located in the nuclei was released from the isolated nuclei, either by DNase I digestion or by treatment with 0.3 M NaCI. Consistently, p45 bound to the DNA-cellulose column was eluted with 0.3 M NaCI. After sequential treatment with DNase I and 2 M NaCI, almost all of the RCC1 protein were released from the nuclei. Thus, RCC1 protein locates on the chromatin and is not a component of the nuclear matrix. In mitotic cells, 1M5 is dispersed into the cytoplasm. Presumably, RCC1 protein plays a role in regulating the onset of chromosome condensation, at the level of transcription or of mRNA maturation.
C HROMOSOME condensation occurs at the transition from G2 to M phase in the cell cycle, with the aid of maturation promoting factor (MPF) ~ (20, 36) . MPF is present in a latent form in the Xenopus oocyte (7, 9) and is specifically activated at mitosis by the translation of an activating agent (for review see reference 10). It is therefore assumed that the interphase cells have a regulatory mechanism which represses expression of this activator protein. This view was supported by cell fusion experiments which revealed that mitosis was delayed in G2 phase cells fused with S phase cells (30) , and by isolation of mutants with defects in negative regulatory factor (s) for MPF activation (23, 26) . In eukaryotic cells, mitosis does not normally occur until DNA synthesis is completed, but, in these mutants, mitosis is prematurely induced at interphase under restrictive conditions.
In one such temperature-sensitive (ts) mutant, tsBN2, from the baby hamster kidney (BHK21) cell line (24, 26) premature chromosome condensation (PCC) occurs at 39.5°C. PCC is a phenomenon that was first identified in cell fusion experiments (30) : after fusion with mitotic cells, interphase cells undergo rapid transformation resembling that of G2-prophase transition, leading to the formation of discrete chromosomes. In the tsBN2 cells, this phenomenon can be induced at the restrictive temperature without fusing mitotic cells. In addition to PCC, all mitotic-specific events (such as phosphorylation of histone H3, appearance of mitotic-specific antigens, and synthesis of p35 protein) occur in interphase tsBN2 cells at the nonpermissive temperature (2, 39, 40) . These mitoticspecific events depend on the synthesis of a new protein (24) .
Consistently, tsBN2 cells showing PCC possess the ability 1 . Abbreviations used in this paper: MPF, maturation promoting factor; PCC, premature chromosome condensation; ts, temperature sensitive.
to condense the chromatin of interphase cells by cell fusion (14) . Thus, chromosome-condensing factor is newly produced in tsBN2 cells at the nonpermissive temperature even in cases of arrest at interphase. As the tsBN2 mutation is recessive in hybrid cells (22) , tsBN2 cells are considered to have a ts defect in the negative regulator for the onset of chromosome condensation, which inhibits the condensation until the G2 phase. We cloned the human RCC1 gene, complementing tsBN2 mutation from HeLa ceils, by DNA-mediated gene transfer (15) . Using the Alu-free DNA fragment of the RCC1 gene, cDNA clones were isolated from Okayama-Berg's cDNA library (25) . While two of these complement the tsBN2 mutation, the 5' base sequence of these clones differs. Since both clones share the open reading frame of 1,263 bp, we considered that this open reading frame may encode the product of the RCC1 gene, RCC1 protein. According to the base sequence of the RCC1 cDNA, the putative RCC1 protein is estimated to have a molecular mass of 45 kD and seven homologous internal repeats of ~60 amino acids.
We prepared antibodies against the peptides of putative RCC1 protein, in attempts to identify the presence of human RCC1 protein in HeLa cells. Using these antibodies, human RCC1 protein was shown to be a new member of the nuclear DNA-binding protein family. It has a molecular mass of 45 kD, the same as estimated from the base sequence of the cloned cDNA.
Preparation and Fractionation of Nuclei
To prepare nuclei, cells were pelleted and washed twice in ice cold hypotonic buffer containing 10 mM Hepes, pH 8.0, 5 mM KCI, and 2 mM MgCl2, then incubated in the hypotonic buffer containing 0.5% NP-40 for 10 rain on ice, and disrupted with a tight-fitting pestle of a Potter homogenizer until virtually all cells were broken (usually 25 strokes). The extent of cell breakage was monitored microscopically. Nuclei were then separated from the cytoplasmic fraction by sedimentation at 1,000 g for 5 rain and washed twice with ice cold hypotonic buffer. The isolated nuclei were suspended in the ice cold hypotonic buffer and kept on ice. All procedures of cell fractiouation were performed with freshly prepared nuclei, at a concentration of l0 s nuclei/ml. In the salt extraction experiments, the hypotonic buffer containing the desired salt concentration was used. Appropriate amounts of a solution containing 2 nag of DNase I per milliliter were added to the nuclei preparation to obtain the desired concentration of nuclease. All experiments were carried out for 10 rain at 0*C. Nuclease treatment was terminated by adding EDTA (final concentration, 5 raM), followed by an additional incubation for 10 rain on ice. Nuclear supernatant and residual nuclei were separated by centrifugation. Each fraction was analyzed by immunobiotting (5, 16) .
Immunobiotting
Cells were lysed in buffer containing 62.5 mM Tris-HCI, pH 6.8, 10 mM 2-mercaptoethanol, 3% (wt/vol) SDS, and 20% glycerol. Cellular proteins were electrophoresed in a 12.5% SDS-polyacrylamide slab gel (19) , and analyzed by immunobiotting, as described previously (5), using the antibody against peptides and a Vectastain ABC kit. Protein concentration was determined by Bradford's method (4) .
Indirect lmmunofluorescence Staining
Cells growing on glass coverslips were fixed in 3 % (wt/vol) paraformaldehyde in PBS, permeabilized with 1% NP-40 in PBS containing glycine, and stained using the anti-peptide 1 and the rhodamine-conjngated goat anti-rabbit IgG (Tago Inc., Burlingame, CA), as described elsewhere (6) . DNA was stained with Hoechst dye 33258 (1 pg/ml) (Hoechst Japan, Ltd., Saitama, Japan).
D NA-binding Assay
Cells labeled with [35S]methionine were lysed in buffer A (10 mM Tris-HCI, pH 8.0, 1 mM MgCle, 0.5% NP-40, 0.45 M NaCI, 1 mM PMSF, and 5 pg/ml Pepstatin) (29) . After dilution with buffer B (10 mM potassium phosphate, pH 6.2, 1 mM MgCI2 0.5% NP-40, 1 mM DTT, 10% glycerol), the lysate was loaded onto the double-stranded calf thymus DNA-cellulose column. Bound proteins were eluted with buffer containing 10 mM Tris-HCI, pH 8.0, 1 mM DTT, and increasing concentrations of NaCI. The flowthrough and the eluted fractions were immunoprecipitated and analyzed by electrophoresis on 12.5 % SDS-polyacrylamide gels. The radioactivity was detected by fluorography.
Results

Preparation of Antibodies to Peptides Encoded by RCC1 cDNA
Using the cloned human RCC1 genomic DNA as a probe, two RCC1 cDNAs complementing the tsBN2 mutation were cloned (25) . These clones have a different 5' untranslated region, but share the open reading frame of 1,263 bp encoding a protein of 45 kD, which is estimated to be a product of the human RCC1 gene. According to the amino acid sequence of this putative RCC1 protein, five peptides were synthesized, as described in Materials and Methods, and the location of each is shown in Fig. 1 . These peptides were conjugated with BSA or keyhole limpet hemocyanin, as a carrier protein, and then used as antigens to immunize the rabbits.
Identification of the Putative RCC1 Protein in Human Cells
Of the five synthetic peptide-specific antibodies, the antipeptide 1 antibody recognized the protein with a molecular mass of 45 kD, detected in the lysate of HeLa cells by immunoblotting ( Fig. 2 ). Other antibodies which recognized the synthetic peptides by Ouchterlony analysis did not specifically recognize any protein by immunoblotting (data not shown). The 45-kD mass is the same as that of the putative RCC1 protein estimated from the base sequence. This p45 protein was also found in two other cell lines, ST2-7 and BN2-pcD51, but not in BHK21 and tsBN2 cells (Fig. 2) . Both ST2-7 and BN2-pcD51 cells~contain the active human RCC1 gene (genomic and its cDNA, respectively) (15, 25) . The presence of p45, therefore, is consistent with the presence of the active human RCC1 gene.
From these results, we conclude that the IM5 protein detected by the antibody to peptide 1 was the product of the human RCC1 gene.
RCC1 Protein Is Located in the Nuclei
HeLa cells were swollen in hypotonic solution and the intact nuclei were collected by gentle centrifugation. Proteins were extracted from both cytoplasmic and nuclear fractions, and analyzed by immunoblotting using anti-peptide 1. As shown in Fig. 3 A, p45 was present only in the nuclear fraction.
The nuclear location of the p45 was further confirmed by indirect immunofluorescence staining. HeLa cells and two other cell lines, tsBN2 and ST2-7, grown on glass coverslips were fixed, permeabilized, and exposed to anti-peptide 1. The presence of antibody was visualized by rhodamineconjugated goat anti-rabbit IgG. The antibody to peptide 1 recognizes only the human RCC1 protein. Therefore, staining of the cells should be consistent with the presence of active human RCC1 protein. As shown in Fig. 4 , the nuclei of both HeLa and ST2-7 were stained but the nuclei of tsBN2 cells were only stained faintly and were barely distinguishable from the cytoplasm. Since both HeLa and ST2-7 cells contain the active human RCC1 gene, these results are consistent with the presence of human RCC1 protein.
Subnuclear Localization of RCCI Protein
To determine whether the RCC1 protein locates on the chro- matin or on the nuclear matrix, isolated nuclei were treated either with nuclease or salt.
The role of DNA in the nuclear association of p45 was first investigated. Nuclei prepared from HeLa cells were incubated in the presence of increasing amounts of DNase I. The release of p45 from the nuclei was monitored by immunoblotting with the anti-peptide 1 antibody. Fig. 5 shows that whereas p45 was completely retained by the nuclei after incubation in the absence of nuclease, even a mild nuclease digestion of DNA released ~80-90% of the total p45. This release of p45 correlates with the extraction of DNA from the nuclei (data not shown). RNA was not required to retain RCCI protein in the nuclei, since p45 was not rclcased from the nuclei after digestion with RNasc A (200/zg/ml) (data not shown). Approximately 10-20% of the total p45 remained associated with the nuclei after digestion with 100 #g/ml of DNase. At physiological salt concentrations, the DNA released from nuclease-treated nuclei is present in nucleoprotein complexes exhibiting characteristic features of chromatin structure, such as nucleosomal organization or histone HI-dependent higher levels of chromatin organization (38) . The p45 proteins present in the nuclei after digestion with 100 #g/ml of DNase I may be attached to such a fragmented chromatin trapped in the nuclei or to the nuclear matrix (3). If the RCC1 protein which is present in the nuclei after DNase I digestion is indeed a component of the nuclear matrix, then the p45 would not be released, even in the presence of 2 M NaC1 (3).
Isolated nuclei were incubated in the presence of increasing concentrations of NaC1. The release of p45 from the nuclei was monitored by immunoblotting with anti-peptide 1. As shown in Fig. 6 , whereas no p45 was released from intact nuclei during incubation in buffer to which no salt had been added, a concentration of 300 mM NaC1 was effective in extracting 80-90% of the total p45. But even in the presence of 400 mM NaCl, some p45 remained in the nuclei. To investigate whether these residual nuclear RCC1 proteins are located on the nuclear matrix, the nuclei were digested with DNase I (100 #g/ml) and then incubated in the presence of 2 M NaC1 (Fig. 7 ). After treatment with 2 M NaCI, p45 was not detectable in the nuclei (Fig. 7 A, NM) , in which fraction only nuclear matrix proteins remained (Fig. 7 B) . Thus, RCC1 protein is located on the chromatin and not on the nuclear matrix. 
RCC1 Proteins in the Mitotic Cell
Cells growing in culture dishes were fixed without hypotonic treatment, so that chromosomes of mitotic cells were condensed, as shown in Fig. 8 
B (arrow points to mitotic cells).
In all mitotic cells examined microscopically, RCC1 proteins were dispersed in the cytoplasm as shown in Fig. 8 A, rather than associated with chromosomes.
Binding of RCC1 Protein to DNA
The finding that RCC1 proteins were released from the nuclei, either by DNase I digestion or by low salt treatment, suggests that RCC1 protein binds to chromatin, as a result of its DNAbinding activity. To investigate the DNA-binding activity of RCC1 protein, the total cellular extract was subjected to chromatography on a DNA-cellulose column (Fig. 9) . Exponentially growing HeLa cells were labeled with [35S]methionine, and the total cellular proteins extracted as described in Materials and Methods. They were then charged onto a column of double-stranded calf thymus DNA-cellulose. The bound proteins were eluted with buffer containing increasing concentrations of NaCI. Flow-through and eluted fractions were immunoprecipitated, using the anti-peptide 1 antibody and analyzed by SDS-PAGE. There were no p45 proteins in the flow-through and washed fractions, hence all the p45 proteins were bound to the DNA-cellulose column. At the concentration of 300 mM NaC1, 80-90% of total p45 proteins were eluted from the DNA-cellulose column.
At the same concentration, two other proteins (>100 kD and 35 kD) were eluted. Since these proteins were immunoprecipitated by anti-peptide 1, these high and low molecular mass proteins may be present with p45 in a complex form.
Discussion
To identify the location of the RCC1 gene product in human cells, we prepared antibodies against peptides synthesized according to the putative human RCC1 protein. One of these antibodies specifically recognized I>45 protein in the extract of HeLa cells. Since the presence of p45 is consistent with the presence of the active human RCC1 gene and the molecular mass is the same as that estimated from the amino acid sequence of putative RCC1 protein, we concluded that the p45 is the human RCC1 protein.
Only the anti-peptide 1 antibody out of five synthetic peptide-specific antibodies recognized the RCC1 protein.
The RCC1 protein has a domain with seven homologous repeats of "°60 amino acids. Peptide 1 is located outside of this domain, while others are located inside the repeated domain. Therefore, the inability of peptide-specific antibodies to recognize RCC1 protein may reflect a particular structure of this protein, as deduced from the base sequence of human RCC1 eDNA (25) .
We obtained evidence for the presence of RCC1 proteins in the nuclei. The nuclei of both HeLa and ST2-7 cells, but not tsBN2 cells were stained with anti-peptide 1. These observations are consistent with the presence of human RCC1 protein. Therefore, the possibility that the nuclei were stained artifactually by the anti-peptide 1 antibody can be ruled out.
DNA plays an important role in locating RCC1 proteins in the nuclei, since almost all the RCC1 proteins were released by the mild digestion of DNA with DNase I. Also, almost all the RCC1 proteins were released from the nuclei by a digestion with 300 mM of NaCI. At the same concentration of NaCI, RCC1 proteins bound to DNA-cellulose columns were effectively eluted. Thus, the RCC1 protein is associated with DNA in a salt labile fashion. Some RCC1 protein was released from nuclei after treatment of 0.1 M NaC1, and a considerable amount was released with 0.2 M NaCI. Presumably, some of the RCC1 protein was free from chromatin in the nucleoplasm. After sequential treatment with DNase I and 2 M NaCI, no RCC1 protein remained in the nuclei. Therefore, the RCCI protein is not a component of the nu- Hence, RCC1 protein did not specifically bind to the mitotic chromosomes.
In addition to the 1>45, two other proteins were eluted from the DNA-cellulose column using the same concentrations of NaCI. Since these proteins were immunoprecipitated by anti-peptide 1, which is specific for human RCC1 protein, it may be that these two other proteins form a complex with RCC1 protein in vivo. These proteins are either essential for RCC1 protein binding to DNA or bind DNA with the aid of RCC1 protein.
We cloned both BHK and tsBN2 RCC1 eDNA, using the human RCCI eDNA as a probe, and confirmed that the wild- 
